(Q34489387)

2 August 2017

1 reference

title

Myasthenia gravis and disorders of neuromuscular transmission (English)

1 reference

2 August 2017

0 references

G Diane Shelton

1

1 reference

2 August 2017

language of work or name

1 reference

1 January 2002

1 reference

Veterinary Clinics of North America: Small Animal Practice

2 August 2017

published in

1 reference

2 August 2017

volume

32

1 reference

2 August 2017

issue

1

1 reference

2 August 2017

page(s)

189-206, vii

1 reference

High-dose intravenous methylprednisolone in myasthenia gravis

2 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0195-5616%2803%2900085-8

7 January 2021

Temperature-dependent inhibition of evoked acetylcholine release in tick paralysis

1 reference

https://api.crossref.org/works/10.1016%2FS0195-5616%2803%2900085-8

7 January 2021

Azathioprine therapy for acquired myasthenia gravis in five dogs

1 reference

https://api.crossref.org/works/10.1016%2FS0195-5616%2803%2900085-8

7 January 2021

Clinical forms of acquired myasthenia gravis in dogs: 25 cases (1988-1995).

1 reference

https://api.crossref.org/works/10.1016%2FS0195-5616%2803%2900085-8

7 January 2021

Acceptors for botulinum neurotoxin reside on motor nerve terminals and mediate its internalization

1 reference

https://api.crossref.org/works/10.1016%2FS0195-5616%2803%2900085-8

7 January 2021

A quantitative study of end-plate potentials in isolated human muscle

1 reference

https://api.crossref.org/works/10.1016%2FS0195-5616%2803%2900085-8

7 January 2021

Autoimmunity in spontaneous myasthenia gravis in dogs

1 reference

https://api.crossref.org/works/10.1016%2FS0195-5616%2803%2900085-8

7 January 2021

Titin antibodies in myasthenia gravis: identification of a major immunogenic region of titin

1 reference

https://api.crossref.org/works/10.1016%2FS0195-5616%2803%2900085-8

7 January 2021

Auto-antibodies to the receptor tyrosine kinase MuSK in patients with myasthenia gravis without acetylcholine receptor antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0195-5616%2803%2900085-8

7 January 2021

Chlorpyrifos Toxicosis in Two Cats

1 reference

https://api.crossref.org/works/10.1016%2FS0195-5616%2803%2900085-8

7 January 2021

Myasthenia gravis in the cat

1 reference

https://api.crossref.org/works/10.1016%2FS0195-5616%2803%2900085-8

7 January 2021

A treatment algorithm for autoimmune myasthenia in adults.

1 reference

https://api.crossref.org/works/10.1016%2FS0195-5616%2803%2900085-8

7 January 2021

Focal myasthenia gravis as a paraneoplastic syndrome of canine thymoma: improvement following thymectomy

1 reference

https://api.crossref.org/works/10.1016%2FS0195-5616%2803%2900085-8

7 January 2021

Treatment of myasthenia gravis with methylprednisolone pulse: a double blind study

1 reference

https://api.crossref.org/works/10.1016%2FS0195-5616%2803%2900085-8

7 January 2021

https://api.crossref.org/works/10.1016%2FS0195-5616%2803%2900085-8

1 reference

7 January 2021

Anconeus muscle: a human muscle preparation suitable for in-vitro microelectrode studies

1 reference

https://api.crossref.org/works/10.1016%2FS0195-5616%2803%2900085-8

7 January 2021

Synaptic vesicle abnormality in familial infantile myasthenia

1 reference

https://api.crossref.org/works/10.1016%2FS0195-5616%2803%2900085-8

7 January 2021

Myasthenia gravis without acetylcholine-receptor antibody: a distinct disease entity

1 reference

https://api.crossref.org/works/10.1016%2FS0195-5616%2803%2900085-8

7 January 2021

Ryanodine receptor autoantibodies in myasthenia gravis patients with a thymoma

1 reference

https://api.crossref.org/works/10.1016%2FS0195-5616%2803%2900085-8

7 January 2021

Ryanodine receptor antibodies related to severity of thymoma associated myasthenia gravis

1 reference

https://api.crossref.org/works/10.1016%2FS0195-5616%2803%2900085-8

7 January 2021

https://api.crossref.org/works/10.1016%2FS0195-5616%2803%2900085-8

1 reference

7 January 2021

Congenital canine myasthenia gravis: I. Deficient junctional acetylcholine receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0195-5616%2803%2900085-8

7 January 2021

Congenital canine myasthenia gravis: II. Acetylcholine receptor metabolism

1 reference

https://api.crossref.org/works/10.1016%2FS0195-5616%2803%2900085-8

7 January 2021

Diagnostic sensitivity of the laboratory tests in myasthenia gravis

1 reference

https://api.crossref.org/works/10.1016%2FS0195-5616%2803%2900085-8

7 January 2021

Myasthenia gravis associated with cutaneous lymphoma in a dog

1 reference

https://api.crossref.org/works/10.1016%2FS0195-5616%2803%2900085-8

7 January 2021

Familial Infantile Myasthenia

1 reference

https://api.crossref.org/works/10.1016%2FS0195-5616%2803%2900085-8

7 January 2021

Acquired myasthenia gravis: what we have learned from experimental and spontaneous animal models

1 reference

https://api.crossref.org/works/10.1016%2FS0195-5616%2803%2900085-8

7 January 2021

Myasthenia gravis: lessons from the past 10 years

1 reference

https://api.crossref.org/works/10.1016%2FS0195-5616%2803%2900085-8

7 January 2021

Risk factors for acquired myasthenia gravis in cats: 105 cases (1986-1998).

1 reference

https://api.crossref.org/works/10.1016%2FS0195-5616%2803%2900085-8

7 January 2021

Titin and ryanodine receptor autoantibodies in dogs with thymoma and late-onset myasthenia gravis

1 reference

https://api.crossref.org/works/10.1016%2FS0195-5616%2803%2900085-8

7 January 2021

Titin Antibodies in Patients with Late Onset Myasthenia Gravis: Clinical Correlations

1 reference

https://api.crossref.org/works/10.1016%2FS0195-5616%2803%2900085-8

7 January 2021

Seronegative myasthenia gravis

1 reference

https://api.crossref.org/works/10.1016%2FS0195-5616%2803%2900085-8

7 January 2021

Highly purified oligo-His tagged human recombinant alpha(1)-AChR is immunogenic in vivo and suitable for T cell stimulation in vitro in experimental and human myasthenia gravis

1 reference

https://api.crossref.org/works/10.1016%2FS0195-5616%2803%2900085-8

7 January 2021

Thymic B lymphocyte clones from patients with myasthenia gravis secrete monoclonal striational autoantibodies reacting with myosin, alpha actinin, or actin

1 reference

https://api.crossref.org/works/10.1016%2FS0195-5616%2803%2900085-8

7 January 2021

Molecular cloning of the canine nicotinic acetylcholine receptor alpha-subunit gene and development of the ELISA method to diagnose myasthenia gravis

1 reference

https://api.crossref.org/works/10.1016%2FS0195-5616%2803%2900085-8

7 January 2021

10.1016/S0195-5616(03)00085-8

Identifiers

DOI

1 reference

2 August 2017

1 reference